These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7190831)

  • 21. Measurement of thymosin alpha 1 by disassociation microELISA.
    Mutchnick MG; Keren DF; Weller FE; McClure JE; Goldstein AL
    J Immunol Methods; 1983 May; 60(1-2):53-60. PubMed ID: 6189912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide.
    Goldstein AL; Low TL; McAdoo M; McClure J; Thurman GB; Rossio J; Lai CY; Chang D; Wang SS; Harvey C; Ramel AH; Meienhofer J
    Proc Natl Acad Sci U S A; 1977 Feb; 74(2):725-9. PubMed ID: 265536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of synthetic thymosin beta 9 fragments on low E-rosette-forming cells of lupus nephritis patients.
    Abiko T; Sekino H
    J Appl Biochem; 1983 Dec; 5(6):446-52. PubMed ID: 6236194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The chemistry and biology of thymosin. II. Amino acid sequence analysis of thymosin alpha1 and polypeptide beta1.
    Low TL; Goldstein AL
    J Biol Chem; 1979 Feb; 254(3):987-95. PubMed ID: 762108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms and prevention of trifluoroacetylation in solid-phase peptide synthesis.
    Kent SB; Mitchell AR; Engelhard M; Merrifield RB
    Proc Natl Acad Sci U S A; 1979 May; 76(5):2180-4. PubMed ID: 287055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A radioimmunoassay for thymosin alpha-1.
    Incefy GS; Ishimura K; Wang JG; Unson CG; Erickson BW
    J Immunol Methods; 1986 May; 89(1):9-17. PubMed ID: 3701071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of the protected tridecapeptide (56-68) of the VH domain of mouse myeloma immunoglobulin M603 and its reattachment to resin supports.
    Voss C; Dimarchi R; Whitney DB; Tjoeng FS; Merrifield RB; Tam JP
    Int J Pept Protein Res; 1983 Aug; 22(2):204-13. PubMed ID: 6618764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of synthetic thymosin alpha 1 C-terminal peptides in the azathioprine E-rosette inhibition assay.
    Ciardelli TL; Incefy GS; Birr C
    Biochemistry; 1982 Aug; 21(18):4233-7. PubMed ID: 6982069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymosin alpha 1 and polypeptide beta 1.
    Low TL; Goldstein AL
    Methods Enzymol; 1985; 116():233-48. PubMed ID: 4088086
    [No Abstract]   [Full Text] [Related]  

  • 30. Thymosin alpha 1: biological activities, applications and genetic engineering production.
    Li J; Liu CH; Wang FS
    Peptides; 2010 Nov; 31(11):2151-8. PubMed ID: 20699109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of a thymosin beta 4-like peptide, thymosin beta Met9, and its effect on low E-rosette-forming lymphocytes of lupus nephritis patients.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2301-4. PubMed ID: 2279297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymosin alpha 1 is a native peptide in several tissues.
    Franco FJ; Diaz C; Barcia M; Freire M
    Biochim Biophys Acta; 1992 Mar; 1120(1):43-8. PubMed ID: 1554740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid-phase syntheses of two deacetyl-thymosin alpha 1 analogues with substitution at position 21 and their effects on low E-rosette-forming lymphocytes of uremic patients.
    Abiko T; Sekino H
    Biotechnol Ther; 1992; 3(3-4):159-68. PubMed ID: 1303729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid-phase synthesis of crystalline glucagon.
    Mojsov S; Merrifield RB
    Biochemistry; 1981 May; 20(10):2950-6. PubMed ID: 7248261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymosins: structure, function and therapeutic applications.
    Low TL; Goldstein AL
    Thymus; 1984; 6(1-2):27-42. PubMed ID: 6087503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation of thymosin alpha 1 from thymosin fraction 5 of different species by high-performance liquid chromatography.
    Low TL; McClure JE; Naylor PH; Spangelo BL; Goldstein AL
    J Chromatogr; 1983 Aug; 266():533-44. PubMed ID: 6630360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solid-phase synthesis of a peptide derivative of thymosin alpha1 and initial studies on its (99m)Tc-radiolabelling.
    Klimentzou P; Beck A; Varvarigou A; Tsitsilonis O; Voelter W; Pirmettis I; Papadopoulos M; Livaniou E; Zikos C
    Chem Biol Drug Des; 2007 Jul; 70(1):40-6. PubMed ID: 17630993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human plasma apolipoprotein C-II: total solid-phase synthesis and chemical and biological characterization.
    Fairwell T; Hospattankar AV; Brewer HB; Khan SA
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4796-800. PubMed ID: 3474626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-step hard acid deprotection/cleavage procedure for solid phase peptide synthesis.
    Nomizu M; Inagaki Y; Yamashita T; Ohkubo A; Otaka A; Fujii N; Roller PP; Yajima H
    Int J Pept Protein Res; 1991 Feb; 37(2):145-52. PubMed ID: 2019476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prothymosin alpha: isolation and properties of the major immunoreactive form of thymosin alpha 1 in rat thymus.
    Haritos AA; Goodall GJ; Horecker BL
    Proc Natl Acad Sci U S A; 1984 Feb; 81(4):1008-11. PubMed ID: 6583693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.